Hospitalisations decline with no ill effect among VA patients

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.436, 2003-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natalizumab reduces hospitalisations in patients with CD

By  

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

The Effect of Telephone-Facilitated Depression Care on Older, Medically Ill Patients

By Pickett Yolonda   Kennedy Gary   Freeman Katherine   Cummings Johnine   Woolis William  

The Journal of Behavioral Health Services & Research, Vol. 41, Iss. 1, 2014-01 ,pp. : 90-96

Springer Publishing Company

Access to resources Recommend Favorite

Valsartan reduces heart failure hospitalisations and norepinephrine levels in patients with heart failure

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Valsartan reduces heart failure hospitalisations and norepinephrine levels in patients with heart failure

By  

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes: In Patients with Bipolar I Disorder in France

By de Zelicourt M.  

PharmacoEconomics, Vol. 21, Iss. 15, 2003-01 ,pp. : 1081-1090

Adis International

Access to resources Recommend Favorite